Broadfin Healthcare Master Fund Ltd
CIK 1511900 · last filed 2022-02-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$181.1K
Companies
9
Total Filings
18
Lifetime Open-Market Net
-$21.67M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI) Delisted | Director | 7,588,395 | $5.59 | $42.42M | $0 | 1 | 2022-02-15 |
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Director | 3,130,573 | $21.64 | $67.75M | $0 | 1 | 2019-02-04 |
| Societal CDMO, Inc. (REPH) Delisted | 10%+ Owner | 2,476,025 | $2.09 | $5.17M | -$13.53M | 3 | 2017-12-22 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 2,728,601 | $58.70 | $160.17M | -$3.25M | 1 | 2017-11-20 |
| Corium International, Inc. (CORI) Delisted | 10%+ Owner | 3,593,626 | — | — | -$16.44M | 1 | 2017-11-17 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | 10%+ Owner | 5,184,942 | — | — | $0 | 1 | 2017-05-22 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | 10%+ Owner | 7,599,869 | — | — | $12.20M | 2 | 2017-02-09 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | 10%+ Owner | 4,361,291 | — | — | $393.8K | 1 | 2016-09-14 |
| SSKN | 10%+ Owner | 1,208,297 | $0.15 | $181.1K | -$1.04M | 1 | 2016-03-14 |
Recent Filings · Page 2 of 2
18 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-11-24 | Societal CDMO, Inc. (REPH) Delisted | Sell (S) | −516,624 | -$4.88M | EDGAR |
| 2017-11-20 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −180,000 | -$3.25M | EDGAR |
| 2017-11-17 | Corium International, Inc. (CORI) Delisted | Sell (S) | −1,500,000 | -$16.44M | EDGAR |
| 2017-05-22 | ARATANA THERAPEUTICS, INC. (PETX) Delisted | Exer (X) | +2,188,500 | $16.41M | EDGAR |
| 2017-02-09 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Sell (S) | −1,053,900 | -$10.23M | EDGAR |
| 2016-09-14 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Buy (P) | +225,000 | $393.8K | EDGAR |
| 2016-03-14 | SSKN | Sell (S) | −798,000 | -$1.04M | EDGAR |
| 2014-07-23 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Buy (P) | +4,876,308 | $22.43M | EDGAR |
Showing 11–18 of 18
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.